Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) Operating Leases (2024 - 2026)

Updated

Adia Nutrition's Operating Leases was $31,809 in Q1 2026, down 30.7% from the prior quarter.

Analysis

Adia Med (ADIA) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025, Operating Leases at Adia Nutrition came in at $45,918, down 55.9% from FY2024.

  • In earlier years, Operating Leases was $104,089 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,267.00
Mar 31, 2026 31,809.00
Dec 31, 2025 45,918.00
Dec 31, 2024 104,089.00
API Access

Adia Med Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ADIA&period=max&api_key=YOUR_API_KEY